Edges in Network
| Network | GSE5851_top8000 - GSE5851 - SiGN-BN NNSR |
| Network Description | Phase II exploratory pharmacogenomics study of cetuximab monotherapy in patients with advanced metastatic CRC |
| Node | ALOX5AP |
| Upstream (Parents) |
|---|
| (<<) BCL2A1 → ALOX5AP |
| (<<) TREM1 → ALOX5AP |
| (<<) FCGR2A → ALOX5AP |
| (<<) VIM → ALOX5AP |
| (<<) NCF2 → ALOX5AP |
| (<<) PLAUR → ALOX5AP |
| Downstream (Children) |
|---|
| ALOX5AP → NTN3 (>>) |
| ALOX5AP → AGPAT4 (>>) |
| ALOX5AP → CCL8 (>>) |
| ALOX5AP → BCL2A1 (>>) |
| ALOX5AP → S100A4 (>>) |
| ALOX5AP → SLC2A14///SLC2A3 (>>) |
| ALOX5AP → CLEC5A (>>) |
| ALOX5AP → SLC2A5 (>>) |
| ALOX5AP → OLR1 (>>) |
| ALOX5AP → TREM1 (>>) |
| ALOX5AP → COL7A1 (>>) |
| ALOX5AP → ALOX5 (>>) |
| ALOX5AP → FCGR2A (>>) |
| ALOX5AP → DGCR2 (>>) |
| ALOX5AP → CSF2RA (>>) |
| ALOX5AP → IL1B (>>) |
| ALOX5AP → LSP1 (>>) |
| ALOX5AP → COL13A1 (>>) |
| ALOX5AP → NCF2 (>>) |
